X
Xponance’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $83.8M | Buy |
451,275
+107,804
| +31% | +$20M | 0.7% | 19 |
|
2025
Q1 | $72M | Buy |
343,471
+4,597
| +1% | +$963K | 0.7% | 19 |
|
2024
Q4 | $60.2M | Sell |
338,874
-631
| -0.2% | -$112K | 0.55% | 24 |
|
2024
Q3 | $67M | Buy |
339,505
+6,919
| +2% | +$1.37M | 0.65% | 20 |
|
2024
Q2 | $57M | Sell |
332,586
-86,817
| -21% | -$14.9M | 0.58% | 23 |
|
2024
Q1 | $76.4M | Buy |
419,403
+6,803
| +2% | +$1.24M | 0.8% | 17 |
|
2023
Q4 | $63.9M | Buy |
412,600
+7,001
| +2% | +$1.08M | 0.77% | 18 |
|
2023
Q3 | $60.5M | Buy |
405,599
+3,109
| +0.8% | +$463K | 0.82% | 16 |
|
2023
Q2 | $54.2M | Buy |
402,490
+4,966
| +1% | +$669K | 0.72% | 17 |
|
2023
Q1 | $63.4M | Buy |
397,524
+8,004
| +2% | +$1.28M | 0.93% | 13 |
|
2022
Q4 | $63M | Buy |
389,520
+34,407
| +10% | +$5.56M | 1.02% | 12 |
|
2022
Q3 | $47.7M | Buy |
355,113
+25,491
| +8% | +$3.42M | 0.92% | 12 |
|
2022
Q2 | $50.5M | Sell |
329,622
-8,602
| -3% | -$1.32M | 1.01% | 11 |
|
2022
Q1 | $54.8M | Buy |
338,224
+28,895
| +9% | +$4.68M | 0.91% | 12 |
|
2021
Q4 | $41.9M | Buy |
309,329
+24,162
| +8% | +$3.27M | 0.66% | 21 |
|
2021
Q3 | $30.8M | Sell |
285,167
-50,291
| -15% | -$5.42M | 0.58% | 23 |
|
2021
Q2 | $37.8M | Buy |
335,458
+10,375
| +3% | +$1.17M | 0.69% | 16 |
|
2021
Q1 | $35.2M | Sell |
325,083
-136
| -0% | -$14.7K | 0.75% | 19 |
|
2020
Q4 | $34.8M | Buy |
325,219
+1,752
| +0.5% | +$188K | 0.76% | 19 |
|
2020
Q3 | $28.3M | Sell |
323,467
-17,198
| -5% | -$1.51M | 0.7% | 24 |
|
2020
Q2 | $33.4M | Buy |
+340,665
| New | +$33.4M | 0.86% | 18 |
|